What This Document Is
This document is a comprehensive final review for NUR 3145 Pharmacotherapeutics at Florida Atlantic University. It consolidates key information from multiple chapters—12, 25, 26, 27, 35, 36, 37, and 38—to aid in exam preparation. The review focuses on pharmacological concepts within the context of nursing practice, covering a wide range of drug classes and associated patient care considerations.
Why This Document Matters
This review is essential for students preparing for the final exam in Pharmacotherapeutics. It’s designed to help nursing students efficiently revisit core concepts, identify knowledge gaps, and reinforce their understanding of drug mechanisms, therapeutic uses, adverse effects, and nursing responsibilities. It’s most valuable when used *in conjunction with* course lectures, textbooks, and other assigned materials. This review serves as a focused tool for self-assessment and targeted study.
Common Limitations or Challenges
This document is a *review* and does not replace the need for a thorough understanding of the foundational material presented throughout the semester. It provides a condensed overview and does not include detailed explanations of complex physiological processes or in-depth discussions of research findings. It is not a substitute for clinical judgment or comprehensive patient assessment.
What This Document Provides
This review includes:
* Key concepts related to antimalarial and antiparasitic therapies (Chapter 12), including nursing assessments, patient teaching, and adverse effects.
* Information on centrally acting muscle relaxants and multiple sclerosis medications (Chapter 25), focusing on nursing assessments and priority diagnoses.
* A summary of pain management strategies (Chapter 26), including narcotics, PCA, and non-pharmacological interventions.
* An overview of anesthesia and related medications (Chapter 27), covering phases of anesthesia and nursing assessments.
* Details on hormone therapies (Chapters 35 & 36), including goserelin, desmopressin, octreotide, and corticosteroids, with a focus on nursing assessments and patient teaching.
* Information on thyroid and antithyroid medications (Chapter 37), including levothyroxine and propylthiouracil, and their associated nursing considerations.
* A review of antidiabetic medications and related concepts (Chapter 38), including insulin types, DKA management, and oral hypoglycemic agents.
This preview *does not* include practice questions, detailed drug calculations, or comprehensive case studies. It is a high-level overview of the topics covered in the full review document.